| abstract |
(A) General formula (I) [Chemical 1] A 1-thio-D-glucitol compound represented by: (B) one or more selected from the group consisting of biguanides, insulin secretagogues, insulin sensitivity enhancers, insulin, dipeptidyl peptidase IV inhibitors, α-glucosidase inhibitors and GLP-1 agonists, A pharmaceutical comprising a combination of is excellent in the prevention and treatment of diabetes, diabetes-related diseases or diabetic complications, and has no side effects. [Selection figure] None |